We are pleased to share that Jeremy Rich, MD, MHS, MBA, deputy director, UPMC Hillman Cancer Center, has been selected and agreed to serve as interim director, effective Aug. 7, to see us through the transition period with Robert Ferris, MD,…

As part of our strategic planning and our evolving plan to enhance diversity, we are realigning our leadership to better serve our community. We have consolidated our three population-based Associate Director (AD) roles into two: AD for Community Outreach and…

After a national search and with approval of the External Advisory Board, UPMC Hillman Cancer Center is pleased to announce Jason J. Luke, MD, FACP, has been appointed the Associate Director (AD) of Clinical Research. Dr. Luke served as the…

After a national search, we are pleased to announce Theresa (Tess) Cummings, RN, DBA, CCRP as the new Associate Director for Research Administration at UPMC Hillman Cancer Center, effective November 1, 2023. In this role, Dr. Cummings is a member…

UPMC Hillman Cancer Center is pleased to announce Patricia L. Opresko, PhD, as the Dr. Bernard F. Fisher Chair for Breast Cancer Discovery Science, a newly formed chair being launched this year. Dr. Opresko was nominated for this appointment because…

UPMC Hillman Cancer Center is very pleased to announce Diwakar Davar, MD, MS, as clinical director for the Melanoma and Skin Cancer Program at UPMC Hillman, effective March 1, 2023. Dr. Davar is a medical oncologist and hematologist at UPMC…

Yael Schenker, MD, MAS, has been appointed to the position of Associate Director for Education and Training, focusing on clinical investigators at UPMC Hillman Cancer Center. Dr. Schenker will work closely and in partnership with Associate Director Chris Bakkenist, who…

Jason J. Luke, MD, FACP, will be the Interim Associate Director for Clinical Research at UPMC Hillman Cancer Center beginning February 1, 2023. Dr. Luke is currently Director of Hillman’s Immunotherapy and Drug Development Center and a member of the…